LINC00460 drives clear cell renal cell carcinoma progression via complement/coagulation and p53 pathways: a potential therapeutic target.

Dong B, Liu S, Wang W, Wang J

Open source

DOI
10.62347/ovhg6077
Published
2026
Container
American journal of translational research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.62347/ovhg6077,
  title = {LINC00460 drives clear cell renal cell carcinoma progression via complement/coagulation and p53 pathways: a potential therapeutic target.},
  author = {Dong B and Liu S and Wang W and Wang J},
  year = {2026},
  journal = {American journal of translational research},
  doi = {10.62347/ovhg6077},
  url = {https://doi.org/10.62347/ovhg6077}
}

RIS

TY  - JOUR
TI  - LINC00460 drives clear cell renal cell carcinoma progression via complement/coagulation and p53 pathways: a potential therapeutic target.
AU  - Dong B
AU  - Liu S
AU  - Wang W
AU  - Wang J
PY  - 2026
JO  - American journal of translational research
DO  - 10.62347/ovhg6077
UR  - https://doi.org/10.62347/ovhg6077
ER  - 

APA

B, D., S, L., W, W., & J, W. (2026). LINC00460 drives clear cell renal cell carcinoma progression via complement/coagulation and p53 pathways: a potential therapeutic target.. American journal of translational research. https://doi.org/10.62347/ovhg6077

Source records